Early Treatment of High Risk Chronic Lymphocytic Leukemia with Alemtuzumab, Rituximab and PGG Beta Glucan is Well Tolerated and Achieves High Complete Remission Rates

av Zent, Clive S., Call, Timothy G., Bowen, Deborah A., Conte, Michael J., LaPlant, Betsy R., Witzig, Thomas E., Ansell, Stephen M., Weiner, George J.
I publikationen Leuk Lymphoma (2015)

Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone

av BOWEN, DEBORAH A., CALL, TIMOTHY G., SHANAFELT, TAIT D., KAY, NEIL E., SCHWAGER, SUSAN M., REINALDA, MEGAN S., RABE, KARI G., SLAGER, SUSAN L., ZENT, CLIVE S.
Publicerad 2010

Statin and Non-steroidal Anti-inflammatory Drug (NSAID) Use In Relation to Clinical Outcome Among Patients with Rai Stage 0 Chronic Lymphocytic Leukemia (CLL)

av Shanafelt, Tait D., Rabe, Kari G., Kay, Neil E., Zent, Clive S., Call, Timothy G., Slager, Susan L., Bowen, Deborah A., Schwager, Susan M., Nowakowski, Grzegorz S.
Publicerad 2010

Addition of GM-CSF Does Not Improve Response to Early Treatment of High Risk Chronic Lymphocytic Leukemia with Alemtuzumab and Rituximab

av Zent, Clive S., Wu, Wenting, Bowen, Deborah A., Hanson, Curtis A., Pettinger, Adam M., Shanafelt, Tait D., Kay, Neil E., Leis, Jose F., Call, Timothy G.
I publikationen Leuk Lymphoma (2012)

Use of Positron Emission Tomography-Computerized Tomography (PET-CT) in the Management of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL)

av Conte, Michael J., Bowen, Deborah A., Wiseman, Gregory A., Rabe, Kari G., Slager, Susan L., Schwager, Susan M., Call, Timothy G., Viswanatha, David S., Zent, Clive S.
I publikationen Leuk Lymphoma (2014)

Validation of a New Prognostic Index for Patients With Chronic Lymphocytic Leukemia (CLL)

av Shanafelt, Tait D., Jenkins, Greg, Call, Timothy G., Zent, Clive S., Slager, Susan, Bowen, Deborah A., Schwager, Susan, Hanson, Curtis A., Jelinek, Diane F., Kay, Neil E.
Publicerad 2009

The Physician - Patient Relationship and Quality of Life: Lessons from Chronic Lymphocytic Leukemia

av Shanafelt, Tait D., Bowen, Deborah A., Venkat, Chaya, Slager, Susan L., Zent, Clive S., Kay, Neil E., Reinalda, Megan, Tun, Han, Sloan, Jeff A., Call, Timothy G.
Publicerad 2008

Early Treatment of High Risk Chronic Lymphocytic Leukemia with Alemtuzumab and Rituximab

av Zent, Clive S., Call, Timothy G., Shanafelt, Tait D., Tschumper, Renee T., Jelinek, Diane F., Bowen, Deborah A., Secreto, Charla R., LaPlant, Betsy R., Kabat, Brian F., Kay, Neil E.
Publicerad 2008

Akt Inhibitor MK2206 Selectively Targets CLL B-cell Receptor Induced Cytokines, Mobilizes Lymphocytes and Synergizes with Bendamustine to Induce CLL Apoptosis

av Ding, Wei, Shanafelt, Tait D., Lesnick, Connie E., Erlichman, Charles, Leis, Jose F., Secreto, Charla, Sassoon, Traci R., Call, Timothy G., Bowen, Deborah A., Conte, Michael, Kumar, Shaji, Kay, Neil E.
Publicerad 2013

Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes

av Parikh, Sameer A., Rabe, Kari G., Kay, Neil E., Call, Timothy G., Ding, Wei, Schwager, Susan M., Bowen, Deborah A., Conte, Michael, Jelinek, Diane F., Slager, Susan L., Shanafelt, Tait D.
Publicerad 2014

A Phase I Clinical Trial of CpG Oligonucleotide 7909 (PF-03512676) in Patients with Previously Treated Chronic Lymphocytic Leukemia

av Zent, Clive S., Smith, Brian J., Ballas, Zuhair K., Wooldridge, James E., Link, Brian K., Call, Timothy G., Shanafelt, Tait D., Bowen, Deborah A., Kay, Neil E., Witzig, Thomas E., Weiner, George J.
Publicerad 2011

The Prognostic Significance of Cytopenia in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL)

av Zent, Clive S., Ding, Wei, Schwager, Susan M., Reinalda, Megan S., Hoyer, James D., Jelinek, Diane F., Tschumper, Renee C., Bowen, Deborah A., Call, Timothy G., Shanafelt, Tait D., Kay, Neil E., Slager, Susan L.
Publicerad 2008

Autoimmune Cytopenia in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL): Changes in Clinical Presentation and Prognosis

av Zent, Clive S., Ding, Wei, Reinalda, Megan S., Schwager, Susan M., Hoyer, James D., Bowen, Deborah A., Jelinek, Diane F., Tschumper, Renee C., Call, Timothy G., Shanafelt, Tait D., Kay, Neil E., Slager, Susan L.
Publicerad 2009

The Prognostic Importance of T and NK-cells in a Consecutive Series of Newly Diagnosed Patients with Chronic Lymphocytic Leukaemia

av Palmer, Shanique, Hanson, Curtis A., Zent, Clive S., Porrata, Luis F., LaPlant, Betsy, Geyer, Susan M., Markovic, Svetomir N., Call, Timothy G., Bowen, Deborah A., Jelinek, Diane F., Kay, Neil E., Shanafelt, Tait D.
Publicerad 2008

Hematologist/Oncologist Disease-Specific Expertise and Survival: Lessons from Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma(CLL)

av Shanafelt, Tait D., Kay, Neil E., Rabe, Kari G., Inwards, David J., Zent, Clive S., Leis, Jose F., Schwager, Susan M., Thompson, Carrie A., Bowen, Deborah A., Witzig, Thomas E., Slager, Susan L., Call, Timothy G.
Publicerad 2011

Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic Lymphocytic Leukemia

av Shanafelt, Tait D., Call, Tim G., Zent, Clive S., LaPlant, Betsy, Bowen, Deborah A., Roos, Michelle, Secreto, Charla R., Ghosh, Asish K., Kabat, Brian F., Lee, Mao-Jung, Yang, Chung S., Jelinek, Diane F., Erlichman, Charles, Kay, Neil E.
Publicerad 2009

Phase 2 Trial of Daily, Oral Polyphenon E in Patients with Asymptomatic, Rai Stage 0-II Chronic Lymphocytic Leukemia(CLL)

av Shanafelt, Tait D., Call, Tim G., Zent, Clive S., Leis, Jose F., LaPlant, Betsy, Bowen, Deborah A., Roos, Michelle, Laumann, Kristina, Ghosh, Asish K., Lesnick, Connie, Lee, Mao-Jung, Yang, Chung S., Jelinek, Diane F., Erlichman, Charles, Kay, Neil E.
Publicerad 2012

Chemoimmunotherapy for Relapsed/Refractory and Progressive 17p13 Deleted Chronic Lymphocytic Leukemia (CLL) Combining Pentostatin, Alemtuzumab, and Low Dose Rituximab is Effective...

av Zent, Clive S., Taylor, Ronald P., Lindorfer, Margaret A., Beum, Paul V., LaPlant, Betsy, Wu, Wenting, Call, Timothy G., Bowen, Deborah A., Conte, Michael J., Frederick, Lori A., Link, Brian K., Blackwell, Sue E., Veeramani, Suresh, Baig, Nisar A., Viswanatha, David S., Weiner, George J., Witzig, Thomas E.
I publikationen Am J Hematol (2014)

Pharmacovigilance during Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) in Routine Clinical Practice

av Finnes, Heidi D., Chaffee, Kari G., Call, Timothy G., Ding, Wei, Kenderian, Saad S., Bowen, Deborah A., Conte, Michael, McCullough, Kristen B., Merten, Julianna A., Bartoo, Gabriel T., Smith, Matthew D., Leis, Jose, Chanan-Khan, Asher, Schwager, Susan M., Slager, Susan L., Kay, Neil E., Shanafelt, Tait D., Parikh, Sameer A.
I publikationen Leuk Lymphoma (2016)

Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings

av Hampel, Paul J., Chaffee, Kari G., King, Rebecca L., Simonetto, Douglas, Larson, Melissa C., Achenbach, Sara, Call, Timothy G., Ding, Wei, Kenderian, Saad S., Leis, Jose F., Chanan-Khan, Asher A., Bowen, Deborah A., Conte, Michael J., Schwager, Susan M., Hanson, Curtis A., Slager, Susan L., Kay, Neil E., Shanafelt, Tait D., Parikh, Sameer A.
I publikationen Am J Hematol (2017)